“RedShiftBio’s mission is to deploy the power of novel analytical tools in life science research and biopharmaceutical drug development, tackling previously unsolvable problems in structural biology.”

Julien Bradley, CEO

“Single-cell RNA sequencing is a critical tool in understanding complex biological processes. Fluent Biosciences is significantly advancing the field with its scalability, cost-effectiveness, and high-throughput capabilities.”

Brian Mckernan, CEO

“Arbor is focused on bringing novel gene editing approaches to patients with severe genetic diseases. For many genetic diseases, gene editing is one of the best ways to create a life changing therapy.”

Devyn Smith, CEO